Massachusetts General Hospital: New CRISPR C-to-G DNA Base Editor Expands Landscape of Precision Genome Editing
July 24, 2020
July 24, 2020
BOSTON, Massachusetts, July 24 -- Massachusetts General Hospital issued the following news release:
New genome-editing technologies developed by researchers in J. Keith Joung's laboratory at the Massachusetts General Hospital (MGH) have the potential to help understand disease-associated genetic mutations that are based on C-to-G (cytosine to guanine) single base changes. The new base editors are also designed to minimize unintended ("off-target") mutations that could pote . . .
New genome-editing technologies developed by researchers in J. Keith Joung's laboratory at the Massachusetts General Hospital (MGH) have the potential to help understand disease-associated genetic mutations that are based on C-to-G (cytosine to guanine) single base changes. The new base editors are also designed to minimize unintended ("off-target") mutations that could pote . . .